Aprepitant for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy
Crossref DOI link: https://doi.org/10.1007/s10147-016-1081-y
Published Online: 2017-01-31
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Inoue, Takako
Kimura, Madoka
Uchida, Junji
Nishino, Kazumi
Kumagai, Toru
Taniguchi, Junko
Imamura, Fumio
License valid from 2017-01-31